SELLAS LIFE SCIENCES GROUP I (SLS) Stock Cash Flow
NASDAQ:SLS - Nasdaq - US81642T2096 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.13M | -30.88M | -37.34M | -41.30M | -20.70M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -240.00K | |||
| Change In Working Capital | -8.74M | -6.65M | 3.35M | 15.64M | -7.62M | |||
| Interest Paid | N/A | N/A | 525.00K | 320.00K | 10.00K | |||
| Other non cash items | 2.17M | 2.13M | 2.58M | 1.85M | 2.53M | |||
| OPERATING CASH FLOW | -33.47M | -35.40M | -31.41M | -23.81M | -26.02M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -5.50M | -4.50M | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | -5.50M | -4.50M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 43.40M | 46.82M | 22.35M | 23.99M | 12.07M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | -64.00K | -31.00K | 90.00K | N/A | |||
| FINANCING CASH FLOW | 43.34M | 46.76M | 22.32M | 24.08M | 12.07M | |||
| CHANGE IN CASH | 9.87M | 11.36M | -14.60M | -4.23M | -13.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -33.47M | -35.40M | -31.41M | -23.81M | -26.02M | |||
| Capital Expenditure | N/A | 0.00 | -5.50M | -4.50M | N/A | |||
| FREE CASH FLOW | -33.47M | -35.40M | -36.91M | -28.31M | -26.02M | |||
All data in USD